HomeAboutMediaCareersSite MapContactSearch
Geron
PatientsProductsTechnology & ScienceInvestors
print
  • Clinical Trial Information
    • Oncology
    • Telomerase Inhibitor Drug (GRN163L)
    • Telomerase Cancer Vaccine (GRNVAC1)
    • Regenerative Medicine
    • hESC - Derived Therapies
  • Disease Information
    • Cancer
    • Spinal Cord Injury
    • Heart Disease
    • Diabetes
  • Information Request

Information Request

If you would like to join Geron's email distribution list in order to receive current news about the Company, please send an email to info@geron.com with your name and email address.

Information about current and future clinical trials is available on this website at the links to the left. For patient inquiries, please call 650-473-7730.

Visionary Therapeutics
Home | About | Media | Careers | Site Map | Contact | Search
Patients | Products | Technology & Science | Investors
Legal Disclaimer
Copyright © Geron 2008. All rights reserved.
Site design and layout by BFW Interactive